Cargando…

Growth Parameters and Survivability of Saccharomyces boulardii for Probiotic Alcoholic Beverages Development

The aim of this research was to optimize the growth parameters (pH, ethanol tolerance, initial cell concentration and temperature) for Saccharomyces boulardii and its tolerance to in vitro gastrointestinal conditions for probiotic alcoholic beverage development. Placket-Burman screening was used to...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Paula, Breno Pereira, Chávez, Davy William Hidalgo, Lemos Junior, Wilson José Fernandes, Guerra, André Fioravante, Corrêa, Mariana Ferreira Dutra, Pereira, Karen Signori, Coelho, Maria Alice Zarur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747048/ https://www.ncbi.nlm.nih.gov/pubmed/31552002 http://dx.doi.org/10.3389/fmicb.2019.02092

Ejemplares similares

Experience with Saccharomyces boulardii Probiotic in Oncohaematological Patients
por: Sulik-Tyszka, Beata, et al.
Publicado: (2017)

Saccharomyces boulardii: What Makes It Tick as Successful Probiotic?
por: Pais, Pedro, et al.
Publicado: (2020)

Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment
por: Appel-da-Silva, Marcelo C., et al.
Publicado: (2017)

Modification of Salmonella Typhimurium Motility by the Probiotic Yeast Strain Saccharomyces boulardii
por: Pontier-Bres, Rodolphe, et al.
Publicado: (2012)

Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System
por: Hudson, Lauren E., et al.
Publicado: (2016)

Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii
por: Khatri, Indu, et al.
Publicado: (2017)

PROTECTIVE EFFECT OF THE PROBIOTIC Saccharomyces boulardii IN Toxocara canis INFECTION IS NOT DUE TO DIRECT ACTION ON THE LARVAE
por: de Avila, Luciana Farias da Costa, et al.
Publicado: (2013)

Functional Heterologous Protein Expression by Genetically Engineered Probiotic Yeast Saccharomyces boulardii
por: Hudson, Lauren E., et al.
Publicado: (2014)

Heterologous Expression of the Leuconostoc Bacteriocin Leucocin C in Probiotic Yeast Saccharomyces boulardii
por: Li, Ran, et al.
Publicado: (2020)

Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements
por: Rannikko, Juha, et al.
Publicado: (2021)

Probiotic Saccharomyces boulardii in the Treatment of Small Intestinal Bacterial Overgrowth in Decompensated Cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2022)

Development and Characterization of Probiotic Beers with Saccharomyces boulardii as an Alternative to Conventional Brewer’s Yeast
por: Díaz, Ana Belén, et al.
Publicado: (2023)

Gleaning evolutionary insights from the genome sequence of a probiotic yeast Saccharomyces boulardii
por: Khatri, Indu, et al.
Publicado: (2013)

Value‐added probiotic development by high‐solid fermentation of sweet potato with Saccharomyces boulardii
por: Campbell, Carmen, et al.
Publicado: (2016)

Virulence Factors and in-Host Selection on Phenotypes in Infectious Probiotic Yeast Isolates (Saccharomyces ‘boulardii’)
por: Imre, Alexandra, et al.
Publicado: (2021)

Physicochemical and Microbiological Properties of Synbiotic Yogurt Made with Probiotic Yeast Saccharomyces boulardii in Combination with Inulin
por: Sarwar, Abid, et al.
Publicado: (2019)

Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract
por: Hedin, Karl Alex, et al.
Publicado: (2022)

Trehalose Protects the Probiotic Yeast Saccharomyces boulardii against Oxidative Stress-Induced Cell Death
por: Moon, Ji Eun, et al.
Publicado: (2020)

Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review
por: Gopalan, Sarath, et al.
Publicado: (2023)

Influence of technological procedures on viability, probiotic and anti-mycotoxin properties of Saccharomyces boulardii RC009, and biological safety studies
por: Poloni, Valeria Lorena, et al.
Publicado: (2021)

Biocontainment strategies for in vivo applications of Saccharomyces boulardii
por: Hedin, Karl Alex, et al.
Publicado: (2023)

Draft Genome Sequence of the Probiotic Yeast Saccharomyces cerevisiae var. boulardii Strain ATCC MYA-796
por: Batista, T. M., et al.
Publicado: (2014)

S-Adenosyl-L-Methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death
por: Cascio, Vincent, et al.
Publicado: (2013)

Production of neoagarooligosaccharides by probiotic yeast Saccharomyces cerevisiae var. boulardii engineered as a microbial cell factory
por: Jin, Yerin, et al.
Publicado: (2021)

Detoxification of aflatoxin M1 by probiotics Saccharomyces boulardii, Lactobacillus casei, and Lactobacillus acidophilus in reconstituted milk
por: Rezasoltani, Sama, et al.
Publicado: (2022)

Improving therapeutic protein secretion in the probiotic yeast Saccharomyces boulardii using a multifactorial engineering approach
por: Durmusoglu, Deniz, et al.
Publicado: (2023)

Catheter-related Saccharomyces cerevisiae Fungemia Following Saccharomyces boulardii Probiotic Treatment: In a child in intensive care unit and review of the literature
por: Atıcı, Serkan, et al.
Publicado: (2017)

Generation of a Uracil Auxotroph Strain of the Probiotic Yeast Saccharomyces boulardii as a Host for the Recombinant Protein Production
por: Hamedi, Hassan, et al.
Publicado: (2013)

Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice
por: Maioli, Tatiani Uceli, et al.
Publicado: (2014)

An unexpected allergic reaction with Saccharomyces boulardii: a case report
por: Kartal, Ozgur, et al.
Publicado: (2014)

Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice
por: Zhou, Huan, et al.
Publicado: (2018)

Impact of Saccharomyces boulardii on jaundice in premature infants undergoing phototherapy
por: Hu, Di, et al.
Publicado: (2022)

Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast Saccharomyces cerevisiae var. boulardii
por: Offei, Benjamin, et al.
Publicado: (2019)

Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases
por: Kaźmierczak-Siedlecka, Karolina, et al.
Publicado: (2020)

Probiotic Saccharomyces cerevisiae var. boulardii supernatant inhibits survivin gene expression and induces apoptosis in human gastric cancer cells
por: Pakbin, Babak, et al.
Publicado: (2020)

Microbiome Engineering Using Probiotic Yeast: Saccharomyces boulardii and the Secreted Human Lysozyme Lead to Changes in the Gut Microbiome and Metabolome of Mice
por: Kim, Jungyeon, et al.
Publicado: (2023)

Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin
por: Lolis, Nikolaos, et al.
Publicado: (2008)

Saccharomyces cerevisiae boulardii Reduces the Deoxynivalenol-Induced Alteration of the Intestinal Transcriptome
por: Alassane-Kpembi, Imourana, et al.
Publicado: (2018)

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial
por: Villar-García, Judit, et al.
Publicado: (2017)

Strain engineering and metabolic flux analysis of a probiotic yeast Saccharomyces boulardii for metabolizing l-fucose, a mammalian mucin component
por: Kim, Jungyeon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ci6f9oon0sdjunbtb82ln7kst6